REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Contains Seven Members Including Nitrogen, Carbon And Chalcogen > Polycyclo Ring System Which Contains The Seven-membered Hetero Ring As One Of The Cyclos > Tricyclo Ring System Having The Seven-mmbered Hetero Ring As One Of The Cyclos > Ring Nitrogen Is Shared By Plural Cyclos Of The Tricyclo Ring System Ring Nitrogen Is Shared By Plural Cyclos Of The Tricyclo Ring SystemRing Nitrogen Is Shared By Plural Cyclos Of The Tricyclo Ring System patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.02/01/07 - 20070027134 - Crystal form of asenapine maleate The invention relates to an orthorhombic crystal form of compound trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz [2,3:6,7] oxepino [4,5-c] pyrrole (Z)-2-butenedioate, to methods for the preparation of this crystal form and to pharmaceutical compositions comprising an orthorhombic crystal form. ... 10/12/06 - 20060229291 - Concentrated, aqueous solutions of p-methoxybenzoic acid for use in cosmetic and dermatologic formulations The present invention is related to concentrated aqueous solutions of p-methoxybenzoic acid and their production. ... 09/28/06 - 20060217367 - Method of treating anxiety disorders or its pharmaceutically acceptable salt. In another aspect of the invention a pharmaceutical composition is provided comprising an effective amount of Formula I or its pharmaceutically acceptable salt and at least one pharmaceutically acceptable carrier or diluent. ... 09/28/06 - 20060217366 - Method of treating schizophrenia and other disorders or its pharmaceutically acceptable salt. In another aspect of the invention a pharmaceutical composition is provided comprising an effective amount of Formula I or its pharmaceutically acceptable salt and at least one pharmaceutically acceptable carrier or diluent. ... 09/28/06 - 20060217365 - Method of treating mood disorders or its pharmaceutically acceptable salt. In another aspect of the invention a pharmaceutical composition is provided comprising an effective amount of Formula I or its pharmaceutically acceptable salt and at least one pharmaceutically acceptable carrier or diluent. ... 06/15/06 - 20060128688 - Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight The invention provides means for the treatment of schizophrenia with an antipsychotic agent administered to a patient with overweight, or to a patient that was having weight gain due to an antipsychotic agent, or to a patient that needs to be protected against weight increase due to the presence of ... 07/28/05 - 20050165002 - Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type Novel processes for the preparation of a compound of the thiazolo[3,4,5-de][4,1]benzothiazepine type and in particular of 2-imino-9-trifluoromethyl-4,5-dihydro-2H,7H-thiazolo[3,4,5-de][4,1]benzothiazepine 6,6-dioxide methanesulfonate and (R,S)-2-imino-9-trifluoromethyl-4,5-dihydro-2H,7H-thiazolo[3,4,5-de][4,1]benzothiazepine 6-oxide and its enantiomers and their pharmaceutically acceptable salts. ... ### FreshPatents.com Support |